Aggregation-Induced Emission CN-Based Nanoparticles to Alleviate Hypoxic Liver Fibrosis via Triggering HSC Ferroptosis and Enhancing Photodynamic Therapy.
Ming-Xuan LiuYu-Ting CaiRuo-Jia WangPeng-Fei ZhuYan-Chao LiuHao SunYong LingWei-Zhong ZhuJing ChenXiao-Ling ZhangPublished in: ACS applied materials & interfaces (2024)
Hypoxia can lead to liver fibrosis and severely limits the efficacy of photodynamic therapy (PDT). Herein, carbon nitride (CN)-based hybrid nanoparticles (NPs) VPSGCNs@TSI for light-driven water splitting were utilized to solve this problem. CNs were doped with selenide glucose (Se-glu) to enhance their red/NIR region absorption. Then, vitamin A-poly(ethylene glycol) (VA-PEG) fragments and aggregation-induced emission (AIE) photosensitizers TSI were introduced into Se-glu-doped CN NPs (VPSGCNs) to construct VPSGCNs@TSI NPs. The introduction of VA-PEG fragments enhanced the targeting of the NPs to activated hepatic stellate cells (HSCs) and reduced their toxicity to ordinary liver cells. VPSGCN units could trigger water splitting to generate O 2 under 660 nm laser irradiation, improve the hypoxic environment of the fibrosis site, downregulate HIF-1α expression, and activate HSC ferroptosis via the HIF-1α/SLC7A11 pathway. In addition, generated O 2 could also increase the reactive oxygen species (ROS) production of TSI units in a hypoxic environment, thereby completely reversing hypoxia-triggered PDT resistance to enhance the PDT effect. The combination of water-splitting materials and photodynamic materials showed a 1 + 1 > 2 effect in increasing oxygen levels in liver fibrosis, promoting ferroptosis of activated HSCs and reversing PDT resistance caused by hypoxia.
Keyphrases
- photodynamic therapy
- liver fibrosis
- cell death
- cell cycle arrest
- fluorescence imaging
- reactive oxygen species
- induced apoptosis
- endothelial cells
- quantum dots
- lymph node metastasis
- oxide nanoparticles
- poor prognosis
- squamous cell carcinoma
- endoplasmic reticulum stress
- dna damage
- visible light
- type diabetes
- signaling pathway
- metal organic framework
- radiation therapy
- blood pressure
- mass spectrometry
- cell proliferation
- reduced graphene oxide
- glycemic control